How technology transfer expertise became a critical CDMO capability to look out for
Mitigating risks and having clear accountabilities are important drivers for biopharma companies. They need a trusted manufacturing partner to execute their vision for biologics and bring drugs to market safely and quickly.
The tech transfer that accompanies such partnerships is multipronged and complex. However, the right partner can follow systematic steps to allow for smooth execution and thereby facilitate a high success rate regarding CMC related topics during approval processes.
Offered Free by: Lonza
See All Resources from: Lonza
